Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -82,667 | -14,859 | 4,134 | -23,982 | 27,193 |
| Depreciation Amortization | 76,407 | 14,487 | 21,382 | 67,066 | 5,991 |
| Income taxes - deferred | -6,327 | -5,270 | -1,766 | -3,543 | 794 |
| Accounts receivable | -1,305 | -5,630 | -6,216 | 5,855 | -1,839 |
| Accounts payable and accrued liabilities | -11 | 1,965 | -1,100 | 822 | 767 |
| Other Working Capital | -12,123 | -11,821 | -11,956 | -12,948 | -6,668 |
| Other Operating Activity | 24,238 | 25,537 | 3,919 | -20,205 | 10,767 |
| Operating Cash Flow | $-1,788 | $4,409 | $8,397 | $13,065 | $37,005 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 2,501 | 24,965 | 42,518 |
| PPE Investments | -5,427 | -7,486 | -5,143 | -1,628 | -2,827 |
| Net Acquisitions | N/A | N/A | -476 | -94,601 | N/A |
| Investing Cash Flow | $-5,427 | $-7,486 | $-3,118 | $-71,264 | $39,691 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 50,000 | N/A |
| Debt Repayment | N/A | -284 | -201 | -50,558 | N/A |
| Common Stock Issued | 23 | 16 | 1,128 | 1,524 | 22,151 |
| Common Stock Repurchased | -5,000 | N/A | N/A | N/A | -30,000 |
| Other Financing Activity | -1,347 | -4,584 | -7,706 | -4,740 | -293 |
| Financing Cash Flow | $-6,324 | $-4,852 | $-6,779 | $-3,774 | $-8,142 |
| Exchange Rate Effect | 79 | -130 | 69 | 327 | -133 |
| Beginning Cash Position | 86,327 | 94,386 | 95,817 | 157,463 | 89,042 |
| End Cash Position | 72,867 | 86,327 | 94,386 | 95,817 | 157,463 |
| Net Cash Flow | $-13,460 | $-8,059 | $-1,431 | $-61,646 | $68,421 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,788 | 4,409 | 8,397 | 13,065 | 37,005 |
| Capital Expenditure | -5,427 | -7,486 | -5,143 | -1,628 | -2,827 |
| Free Cash Flow | -7,215 | -3,077 | 3,254 | 11,437 | 34,178 |